Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in children

International Journal of Infectious Diseases(2023)

引用 0|浏览17
暂无评分
摘要
•A novel 3.5-day primaquine (PQ) regimen was well tolerated and relatively safe.•Supervised doses given with food ameliorated the gastrointestinal adverse effects.•Pharmacokinetic data support the ultra-short PQ regimens with a twice-daily dosing.•Short-course PQ regimens will likely improve treatment acceptability and adherence.
更多
查看译文
关键词
vivax malaria,short-course,high-dose,liver-stage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要